Medicare Evidence Development and Coverage Advisory Committee Recommends Medicare Reimbursement of Provenge

Yesterday, the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) vote on a number of questions amounted to a recommendation to the Centers for Medicare and Medicaid Services (CMS) to cover Provenge, a therapeutic vaccine for men with advanced prostate cancer.  While the recommendation was not overwhelmingly enthusiastic, Provenge clears one hurdle on its way...Continue reading

New Men’s Health Website Launched by the Agency for Healthcare Research and Quality

A new men’s health website called Healthy Men was launched today by the Agency for Healthcare Research and Quality (AHRQ).  AHRQ falls under the U.S Department of Health & Human Services.  It primarily functions as a research agency and additionally provides research grants to academic institutions, private entities, and public organizations.

Prostate Cancer Screening Policy Update

The Patient Protection and Affordable Care Act (PPACA) is a large piece of legislation that can be confusing.  Much of the legislation leaves the formation of regulations and implementation to the Secretary of the U.S. Department of Health and Human Services.  Men’s Health Network (MHN) is closely monitoring and analyzing regulatory developments for prostate cancer...Continue reading

Scroll to top